"I know folks are getting tired of studies and analysis and they’re ready to see something tangible happen, and I certainly ...

The era of the simple chatbot is over. The new wave of AI tools doesn't just answer questions—they execute entire projects.

Bridgewater, New Jersey Saturday, October 18, 2025, 18:00 Hrs [IST] ...

Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, ...

Biomarkers identified in BriaCell’s Phase 2 study are showing similar and encouraging trends in the ongoing pivotal Phase 3 study of Bria-IMT™ in metastatic breast cancer (MBC)No new safety or ...

Matthew Tracy's presentation in a House subcommittee meeting slammed regulators for 'a wholesale dropping of the ball.' ...

As such, at ESMO 2025, the investigators analyzed patients with or without baseline bone metastases treated with lenvatinib + pembrolizumab versus sunitinib in the CLEAR study with ∼4 years follow-up ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and ...

The FireFusion 2025 Tailboard Talks included short presentations about careers, leadership, AI and fireground operations.

At the fence line of the Pearl Street tank farm, benzene levels were higher than the state’s ambient average guideline. But ...

The proportion of women presenting to Australian general practice with endometriosis almost doubled between 2011‒2021, according to a new study by ...

BRUSSELS/STOCKHOLM/KYIV (Reuters) -Just hours after some 20 Russian drones entered Polish airspace last month, European ...